Literature DB >> 30672105

Long-term survival in visceral transplant recipients in the new era: A single-center experience.

Ahmed M Elsabbagh1,2,3, Jason Hawksworth1,4, Khalid M Khan1, Stuart S Kaufman1, Nada A Yazigi1, Alexander Kroemer1, Coleman Smith1, Thomas M Fishbein1, Cal S Matsumoto1.   

Abstract

There is a paucity of data on long-term outcomes following visceral transplantation in the contemporary era. This is a single-center retrospective analysis of all visceral allograft recipients who underwent transplant between November 2003 and December 2013 with at least 3-year follow-up data. Clinical data from a prospectively maintained database were used to assess outcomes including patient and graft survival. Of 174 recipients, 90 were adults and 84 were pediatric patients. Types of visceral transplants were isolated intestinal transplant (56.3%), combined liver-intestinal transplant (25.3%), multivisceral transplant (16.1%), and modified multivisceral transplant (2.3%). Three-, 5-, and 10-year overall patient survival was 69.5%, 66%, and 63%, respectively, while 3-, 5-, and 10-year overall graft survival was 67%, 62%, and 61%, respectively. In multivariable analysis, significant predictors of survival included pediatric recipient (P = .001), donor/recipient weight ratio <0.9 (P = .008), no episodes of severe acute rejection (P = .021), cold ischemia time <8 hours (P = .014), and shorter hospital stay (P = .0001). In conclusion, visceral transplantation remains a good option for treatment of end-stage intestinal failure with parenteral nutritional complications. Proper graft selection, shorter cold ischemia time, and improvement of immunosuppression regimens could significantly improve the long-term survival.
© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; health services and outcomes research; immunosuppressive regimens - induction; intestinal (allograft) function/dysfunction; intestine/multivisceral transplantation

Year:  2019        PMID: 30672105      PMCID: PMC6591067          DOI: 10.1111/ajt.15269

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  43 in total

1.  Partial abdominal exenteration, ex vivo resection of a large mesenteric fibroma, and successful orthotopic intestinal autotransplantation.

Authors:  A G Tzakis; W De Faria; M Angelis; R Verzaro; A Pinna
Journal:  Surgery       Date:  2000-09       Impact factor: 3.982

2.  The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival.

Authors:  G Bond; J Reyes; G Mazariegos; T Wu; N Schaefer; J Demetris; J J Fung; T E Starzl; K Abu-Elmagd
Journal:  Transplant Proc       Date:  2000-09       Impact factor: 1.066

3.  Multivisceral and isolated intestinal procurement techniques.

Authors:  Hasan Yersiz; John F Renz; Garrett M Hisatake; Sherylin Gordon; Bob H Saggi; Nicholas J Feduska; Ronald W Busuttil; Douglas G Farmer
Journal:  Liver Transpl       Date:  2003-08       Impact factor: 5.799

4.  Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the VIII International Small Bowel Transplant Symposium.

Authors:  P Ruiz; A Bagni; R Brown; G Cortina; N Harpaz; M S Magid; J Reyes
Journal:  Transplant Proc       Date:  2004-03       Impact factor: 1.066

5.  Association of emergence of HLA antibody and acute rejection in intestinal transplant recipients: a possible evidence of acute humoral sensitization.

Authors:  T Kato; K Mizutani; P Terasaki; C Quintini; G Selvaggi; J Thompson; P Ruiz; A Tzakis
Journal:  Transplant Proc       Date:  2006 Jul-Aug       Impact factor: 1.066

6.  Modified multivisceral transplantation with splenopancreatic preservation.

Authors:  Cal S Matsumoto; Thomas M Fishbein
Journal:  Transplantation       Date:  2007-01-27       Impact factor: 4.939

7.  A schema for histologic grading of small intestine allograft acute rejection.

Authors:  Tong Wu; Kareem Abu-Elmagd; Geoffy Bond; Michael A Nalesnik; Parmjeet Randhawa; A Jake Demetris
Journal:  Transplantation       Date:  2003-04-27       Impact factor: 4.939

8.  Isolated intestinal transplantation: proof of clinical efficacy.

Authors:  Thomas M Fishbein; Stuart S Kaufman; Sander S Florman; Gabriel E Gondolesi; Thomas Schiano; Leona Kim-Schluger; Margaret Magid; Noam Harpaz; Alan Tschernia; Andrew Leibowitz; Neal S LeLeiko
Journal:  Transplantation       Date:  2003-08-27       Impact factor: 4.939

Review 9.  Intestinal replacement therapy: timing and indications for referral of patients to an intestinal rehabilitation and transplant program.

Authors:  Thomas M Fishbein; Cal S Matsumoto
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

10.  Chronic renal failure after transplantation of a nonrenal organ.

Authors:  Akinlolu O Ojo; Philip J Held; Friedrich K Port; Robert A Wolfe; Alan B Leichtman; Eric W Young; Julie Arndorfer; Laura Christensen; Robert M Merion
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

View more
  8 in total

Review 1.  Update on immunosuppressive strategies in intestinal transplantation.

Authors:  Jonathan Merola; Abrar Shamim; Joshua Weiner
Journal:  Curr Opin Organ Transplant       Date:  2022-04-01       Impact factor: 2.640

Review 2.  Overview of Physical, Neurocognitive, and Psychosocial Outcomes in Pediatric Intestinal Failure and Transplantation.

Authors:  Charles B Chen; Shreeya Chugh; Masato Fujiki; Kadakkal Radhakrishnan
Journal:  Curr Gastroenterol Rep       Date:  2022-08-30

Review 3.  Innovations in Immunosuppression for Intestinal Transplantation.

Authors:  Harween Dogra; Jonathan Hind
Journal:  Front Nutr       Date:  2022-06-15

4.  Immunologic Complications and Graft Survival in Crohn's Disease and NOD2 Mutant Non-Crohn's Disease Adult Recipients Following Intestine Transplantation.

Authors:  Leonid Belyayev; Jason Hawksworth; Khalid Khan; Stuart Kaufman; Sukanya Subramanian; Alexander Kroemer; Katrina Loh; Raffaele Girlanda; Thomas M Fishbein; Cal S Matsumoto
Journal:  Transplant Direct       Date:  2020-05-21

5.  Living Donor Intestinal Transplantation: Recipient Outcomes.

Authors:  Guosheng Wu; Chaoxu Liu; Xile Zhou; Long Zhao; Weitong Zhang; Mian Wang; Qingchuan Zhao; Tingbo Liang
Journal:  Ann Surg       Date:  2022-08-15       Impact factor: 13.787

6.  Rejection of intestinal allotransplants is driven by memory T helper type 17 immunity and responds to infliximab.

Authors:  Alexander Kroemer; Leonid Belyayev; Khalid Khan; Katrina Loh; Jiman Kang; Anju Duttargi; Harmeet Dhani; Mohammed Sadat; Oswaldo Aguirre; Yuriy Gusev; Krithika Bhuvaneshwar; Bhaskar Kallakury; Christopher Cosentino; Brenna Houlihan; Jamie Diaz; Sangeetha Moturi; Nada Yazigi; Stuart Kaufman; Sukanya Subramanian; Jason Hawksworth; Raffaelle Girlanda; Simon C Robson; Cal S Matsumoto; Michael Zasloff; Thomas M Fishbein
Journal:  Am J Transplant       Date:  2020-09-25       Impact factor: 8.086

7.  The Phenolic Antioxidant 3,5-dihydroxy-4-methoxybenzyl Alcohol (DHMBA) Prevents Enterocyte Cell Death under Oxygen-Dissolving Cold Conditions through Polyphyletic Antioxidant Actions.

Authors:  Moto Fukai; Takuya Nakayabu; Shintaro Ohtani; Kengo Shibata; Shingo Shimada; Soudai Sakamoto; Hirotoshi Fuda; Takayuki Furukawa; Mitsugu Watanabe; Shu-Ping Hui; Hitoshi Chiba; Tsuyoshi Shimamura; Akinobu Taketomi
Journal:  J Clin Med       Date:  2021-05-04       Impact factor: 4.241

8.  Graft Versus Host Disease After Intestinal Transplantation: A Single-center Experience.

Authors:  Stuart S Kaufman; Elsadig Hussan; Alexander Kroemer; Olga Timofeeva; Helena B Pasieka; Juan Francisco Guerra; Nada A Yazigi; Khalid M Khan; Udeme D Ekong; Sukanya Subramanian; Jason S Hawksworth; Raffaelle Girlanda; Shahira S Ghobrial; Thomas M Fishbein; Cal S Matsumoto
Journal:  Transplant Direct       Date:  2021-07-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.